ArticleInfectious diseases of poverty2025
An exploratory study to assess the influence of schistosomiasis on the occurrence of dengue virus in Madagascar.
Article in Infectious diseases of poverty, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Funding
Abstract
backgroundDengue virus (DENV) is the most prevalent mosquito-borne virus worldwide, with approximately half of the world's population at risk of infection. Although it has been shown that parasitic infections can influence viral co-infections the role of schistosomiasis has not yet been explored. The objective of this exploratory study was to investigate the influence of schistosome infection on DENV infection in Madagascar.
methodsBetween March 2020 and October 2022 we recruited participants in the regions of Boeny and Atsinanana to assess the seroprevalence of DENV in the country using highly specific tests for the detection of IgG antibodies and investigated the influence of schistosome infections on DENV infections through a plaque reduction neutralisation test (PRNT). For this, additional participants were recruited in Haute Matsiatra between July 2022 and March 2023, Poisson regression models were used to assess the association of the PRNT results with schistosome infections.
resultsFor the first time, we report a low seroprevalence of DENV (up to 3.3%) in areas with a high prevalence (> 50%) of schistosome infection. Additionally, we could demonstrate that sera derived from schistosome-infected individuals exert a significant antiviral activity against DENV infection (up to 27.5%). A Poisson regression analysis revealed that, among the possible factors assessed, the schistosome infection status was the only factor associated with the inhibitory effects against DENV infection in the PRNT. Finally, we could observe that highest IgE level were found in participants showing the greatest reduction in viral infection in the PRNT.
conclusionsOur data suggest that schistosomiasis might play a protective role against DENV infections. These findings offer new perspectives regarding how chronic parasitic infections affect the dynamics of DENV infections in Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.